Hicet-AX Syrup is a combination pharmaceutical formulation containing Cetirizine dihydrochloride 2.5 mg and Ambroxol hydrochloride 30 mg per 5 ml. Cetirizine is a second-generation antihistamine that selectively inhibits peripheral H1 receptors, effectively alleviating symptoms associated with allergic conditions such as rhinitis, urticaria, and other hypersensitivity reactions by reducing histamine-mediated responses. Ambroxol is a mucolytic agent that enhances mucus clearance by stimulating the production of serous mucus in the respiratory tract, facilitating expectoration and improving airway patency in conditions characterized by excessive or thickened mucus, such as bronchitis and other respiratory tract infections. The synergistic combination of Cetirizine and Ambroxol in Hicet-AX Syrup provides dual therapeutic benefits by simultaneously addressing allergic inflammation and promoting mucus clearance, thereby improving respiratory function and patient comfort. This formulation is indicated for the symptomatic treatment of allergic respiratory disorders accompanied by productive cough and mucus hypersecretion. Hicet-AX Syrup is generally well tolerated; however, it should be used with caution in patients with known hypersensitivity to either component. Dosage and duration of therapy should be individualized based on clinical response and patient age, adhering to established prescribing guidelines.